New approvals: new medication &vaccine highlights
New FDA-Approved Medications
- lixisenatide(Adlyxin): GLP-1 receptor agonist for type 2 diabetes
- lifitegrast ophthalmic solution (Xiidra ophthalmic solution): LFA-1 antagonist for dry eye disease
- sofosbuvir/velpatasvir (Epclusa): HCV nucleotide analog NS5B polymerase inhibitor/HCV NS5A inhibitor for chronic hepatitis C virus infection
Cholera Vaccine Now Available
June 22, 2016: FDA approved Vaxchora. This is a new vaccine to prevent cholera caused by Vibrio cholera serogroup O1. This vaccine is approved for adults aged 18 through 64 traveling to cholera-affected areas. Details about the vaccine:
- Live, oral vaccine
- Single, oral liquid dose, 100 mL
- Taken at least 10 days before travel
- Adverse reactions: tiredness, headache, nausea/vomiting, diarrhea, abdominal pain